Rockville, Maryland — According to state and local economic development sources Cellular Biomedicine Group plans to build out 22,000 square feet of new space in Rockville. The company plans to occupy the new space in Rockville, on or about May 1, 2020. According to the company website Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards.

To learn more about Cellular Biomedicine Group, visit http://www.cellbiomedgroup.com/

Company Contact:
Tony Liu, Chief Executive Officer
tony.liu@cellbiomedgroup.com
https://www.linkedin.com/in/tony-liu-79695a14/
347-905-5663

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved